Tumor-derived CCL2 recruits different subsets of myeloid cells, including TAMs, which contribute to cancer cell proliferation, the inflammatory microenvironment of the tumor, immune response evasion and angiogenesis17,19. This evidence concerns the gene CCL2 and neoplasm.